aspirin has been researched along with hydroxychloroquine in 100 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 51 (51.00) | 18.7374 |
1990's | 5 (5.00) | 18.2507 |
2000's | 11 (11.00) | 29.6817 |
2010's | 20 (20.00) | 24.3611 |
2020's | 13 (13.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Evens, RP | 1 |
Bierbaum, B; Hume, M; Kuriakose, TX; Surprenant, J | 1 |
Mustard, JF; Packham, MA | 1 |
Hirsh, J; Turpie, AG | 1 |
Parisi, AF; Sasahara, AA; Sharma, GV | 1 |
Huguier, M; Uhl, JF | 1 |
Hirsh, J | 1 |
Dettori, AG; Pini, M; Quintavalla, R | 1 |
Latour, JG | 1 |
Hladovec, J | 1 |
Dechavanne, M; Follea, G; Trzeciak, MC | 1 |
Gent, M; Genton, E; Harker, LA; Hirsh, J | 2 |
Gallus, AS; Hirsh, J | 1 |
Smiley, JD | 1 |
Clarke, AK; Currey, HL; Vernon-Roberts, B | 1 |
Klipper, AR; Kolodny, AL | 1 |
Joffe, SN | 1 |
Gent, M; Genton, E; Hirsh, J | 1 |
Green, WT | 1 |
Boisnic, S; Francès, C; Godeau, P; Le Charpentier, Y; Ziza, JM | 1 |
Kremer, JM | 1 |
Fries, JF; Furst, DE; Lenert, L; Singh, G | 1 |
Bird, HA; Dixon, JS; Wright, V | 1 |
Cassidy, JT | 1 |
Didisheim, P; Fuster, V; Kazmier, FJ | 1 |
Bounameaux, Y | 1 |
Smukler, NM | 1 |
Bossa, G; Giordano, M | 1 |
Ignarro, LJ | 2 |
David-Chaussé, F; David-Chaussé, J; Dehais, J; Lagoarde, J; Laporte, G; Picot, C | 1 |
Cloud, RS; Ward, JR | 1 |
Bird, HA; Dixon, JS; Pickup, ME | 1 |
Birgens, HS; Hansen, MS | 1 |
Gall, EP | 1 |
Alepa, FP | 1 |
Bouchier-Hayes, D | 1 |
Baum, J | 2 |
Bird, HA; Leatham, P; Rhind, V; Saunders, A; Wright, V | 1 |
Verstraete, M | 1 |
Turpie, AG | 1 |
Arnett, FC; Dimachkie, MM; Van Horn, G | 1 |
Nasonov, EL | 1 |
JEFFREY, MR | 1 |
DUTHIE, JJ | 1 |
NEWBOULD, BB | 1 |
BOUMA, HG; DEVRIES, K; JANSZ, A; NIEWEG, HO | 1 |
MASON, RM | 1 |
BOUVIER, M; LEJEUNE, E; MAITREPIERRE, J | 1 |
FRANCHIMONT, P; LAMBERT, PH; LAPIERE, CM; LEFEBVRE, P; LISIN, N; SALMON, J; VANCAUWENBERGE, H | 1 |
BARTHOLOMEW, LE | 1 |
Airò, P; Biggioggero, M; Borghi, O; Cimaz, R; Meregalli, E; Meroni, PL; Motta, M; Tincani, A | 1 |
Chang, DM; Chen, CH; Chen, HC; Gao, HW; Huang, GS; Kuo, SY; Lai, JH | 1 |
Brey, RL; Holliday, SL; McLaurin, EY; Williams, P | 1 |
Belizna, CC; Lévesque, H; Richard, V; Shoenfeld, Y; Thuillez, C | 1 |
Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W | 1 |
Laskari, K; Moutsopoulos, HM; Panagiotakos, DB; Tektonidou, MG | 1 |
Bloch, DB; Kroshinsky, D; Sepehr, A; Stone, JH | 1 |
Günther, C; Lee-Kirsch, MA; Meurer, M; Stein, A; Viehweg, A | 1 |
Lim, W; Metjian, A | 1 |
Mutizwa, MM; Ng, SK; Tang, MB | 1 |
Anouti, S; Haddad, F; Koussa, S; Maalouly, G | 1 |
Khamashta, MA; Ruiz-Irastorza, G | 1 |
Foster, CS; Kruh, JN; Yang, P | 1 |
Foroughipour, M; Nikbin, Z; Pezeshki Rad, M; Sahebari, M; Shoeibi, A | 1 |
de Jesús, GR; de Jesús, NR; Levy, RA; Rodrigues, G | 1 |
Botta, A; Bucourt, M; Carbillon, L; Chollet-Martin, S; Chudzinski, A; Cornelis, F; Costedoat-Chalumeau, N; De Carolis, S; Emmanuelli, V; Fain, O; Hachulla, E; Masseau, A; Mekinian, A; Montestruc, F; Nicaise, P; Revaux, A; Subtil, D; Theulin, A | 1 |
Achuthan, S; Ahluwalia, J; Bhalla, A; Chandurkar, N; Malhotra, S; Pareek, A; Shafiq, N | 1 |
Anelli, MG; Cacciapaglia, F; Covelli, M; Iannone, F; Lapadula, G; Rinaldi, A; Scioscia, C; Serafino, L | 1 |
Branch, DW; Hunt, BJ; Khamashta, M; Levy, RA; Middeldorp, S; Pavord, S; Roccatello, D; Ruiz-Irastorza, G; Schreiber, K; Sciascia, S; Tincani, A | 1 |
Dogra, S; Saikia, UN; Sawatkar, G; Vinay, K | 1 |
Fasano, S; Iudici, M; Pantano, I; Pierro, L; Valentini, G | 1 |
Afeltra, A; Fasano, S; Margiotta, DP; Navarini, L; Pantano, I; Pierro, L; Riccardi, A; Valentini, G | 1 |
Fowke, KR; Lajoie, J; Mwangi, L | 1 |
Garabajiu, M; Mazur, M; Mazur-Nicorici, L; Sadovici-Bobeica, V | 1 |
Akolo, M; Birse, K; Boily-Larouche, G; Burgener, A; Chen, Y; Cheruiyot, J; Fowke, KR; Ho, EA; Kimani, J; Kimani, M; Lajoie, J; Mungai, J; Mutch, S; Mwangi, L; Oyugi, J; Romas, L | 1 |
Kemp, M; Thomas, W | 1 |
Benbara, A; Cacciatore, C; Carbillon, L; Carrat, F; Fain, O; Mekinian, A; Nicaise Roland, P; Placais, L | 1 |
Li, XY; Liu, XY; Zhao, JX | 1 |
Acaia, B; Bartoli, F; Borghi, MO; Chighizola, CB; Comerio, C; Ferrazzi, E; Gerosa, M; Lonati, PA; Meroni, PL; Ossola, MW; Pregnolato, F; Raimondo, MG; Trespidi, L | 1 |
Aranda, F; Belizna, C; Larrañaga, G; Latino, JO; Romero, DSF; Udry, S; Wingeyer, SP | 1 |
Arora, K; De, D; Jindal, AK; Joshi, V; Razmi T, M; Suri, D | 1 |
Arslanbekova, M; Aslanova, Z; Babaeva, N; Bitsadze, V; Egorova, E; Gadaeva, Z; Grigoreva, K; Khamani, I; Khizroeva, J; Kunesko, N; Makatsariya, A; Makatsariya, N; Mashkova, T; Mischenko, A; Nakaidze, I; Shkoda, A; Solopova, A; Tincani, A; Tretyakova, M; Tsibizova, V; Vorobev, A | 1 |
Andreoli, L; Aringer, M; Bertsias, G; Boletis, J; Boumpas, DT; Chavatza, K; Doria, A; Fanouriakis, A; Gioti, O; Houssiau, FA; Jayne, D; Kostopoulou, M; Mosca, M; Nikolopoulos, D; Svenungsson, E; Tincani, A; Togia, K | 1 |
Chaturvedi, S; Hussain, H; McCrae, KR; Roberts, JC; Tarantino, MD | 1 |
Leong, PY; Su, YJ; Wang, YH; Wei, JC | 1 |
Al-Adnani, M; Marnerides, A; Moar, L; Nanda, S; Nelson-Piercy, C; Nicolaides, KH; Shangaris, P; Simela, C | 1 |
Craigo, S; Kuller, JA; Norton, ME; Osmundson, SS; Porter, F; Silver, R | 1 |
Graham, D; Nathan, E; Phillips, J | 1 |
Li, Y; Li, YW; Zhang, HX; Zhang, N | 1 |
Abrahams, VM; León-Martínez, D; Lynn, T | 1 |
Bacal, V; Bedaiwy, MA; Hooper, A | 1 |
28 review(s) available for aspirin and hydroxychloroquine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical pharmacology of platelets.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation; Blood Platelets; Cell Membrane; Clofibrate; Cyproheptadine; Dipyridamole; Drug Therapy, Combination; Furosemide; Halofenate; Heparin; Humans; Hydrocortisone; Hydroxychloroquine; Methylprednisolone; Penicillin G; Platelet Aggregation; Propranolol; Prostaglandins; Sulfinpyrazone; Vitamin E | 1977 |
Platelet suppressive therapy.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1978 |
New developments in the detection and prevention of venous thromboembolism.
Topics: Aspirin; Clothing; Dextrans; Electric Stimulation Therapy; Fibrinolytic Agents; Heparin; Hip Joint; Humans; Hydroxychloroquine; Joint Prosthesis; Leg; Neurosurgery; Plethysmography, Impedance; Postoperative Care; Postoperative Complications; Pressure; Pulmonary Embolism; Thrombophlebitis | 1979 |
[Prevention of thrombosis and embolism in digestive surgery].
Topics: Anticoagulants; Aspirin; Coumarins; Dextrans; Digestive System Surgical Procedures; Dipyridamole; Heparin; Humans; Hydroxychloroquine; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Random Allocation; Thromboembolism; Thrombophlebitis | 1979 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thromboembolism; Thrombosis | 1978 |
[Treatment with antiplatelet drugs. Current status of knowledge].
Topics: Aspirin; Blood Platelet Disorders; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dextrans; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Platelet Aggregation; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1979 |
[Clinical prevention of thrombosis by antiplatelet agents].
Topics: Aspirin; Blood Platelets; Clofibrate; Dipyridamole; Humans; Hydroxychloroquine; Sulfinpyrazone; Thrombosis | 1979 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Kidney Diseases; Kidneys, Artificial; Male; Silicone Elastomers; Sulfinpyrazone; Thromboembolism; Thrombosis; Vascular Diseases | 1975 |
Antithrombotic drugs: part II.
Topics: Anabolic Agents; Ancrod; Animals; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyridamole; Fibrinolytic Agents; Humans; Hydroxychloroquine; Myocardial Infarction; Plasminogen Activators; Streptokinase; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Urokinase-Type Plasminogen Activator | 1976 |
The prevention of postoperative deep vein thrombosis.
Topics: Adult; Aspirin; Atmospheric Pressure; Clinical Trials as Topic; Dextrans; Electric Stimulation; Ethylestrenol; Foot; Heparin; Humans; Hydroxychloroquine; Leg; Middle Aged; Movement; Muscles; Phenformin; Polysaccharides; Postoperative Complications; Regional Blood Flow; Sulfuric Acids; Thrombophlebitis | 1975 |
Severe rheumatoid arthritis: current options in drug therapy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Arthritis, Rheumatoid; Aspirin; Clinical Protocols; Cyclosporins; Drug Therapy, Combination; Fatty Acids, Omega-3; Glucosamine; Humans; Hydroxychloroquine; Interferon-gamma; Methotrexate; Ribose | 1990 |
Rheumatoid arthritis.
Topics: Antigen-Antibody Reactions; Arthritis, Juvenile; Arthritis, Rheumatoid; Aspirin; Biopsy; Chloroquine; Gold; Humans; Hydroxychloroquine; Immunoglobulins; Lysosomes; Prednisone; Rheumatic Nodule; Rheumatoid Factor; Synovial Membrane; Synovitis; Tenosynovitis; Vascular Diseases | 1973 |
Platelet inhibition in the management of thrombosis.
Topics: Aspirin; Blindness; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dextrans; Dipyridamole; Fibrinogen; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Iodine Radioisotopes; Molecular Weight; Myocardial Infarction; Phlebography; Renal Dialysis; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Thrombosis | 1974 |
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
Topics: Anticoagulants; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Flurbiprofen; Humans; Hydroxychloroquine; Lidocaine; Platelet Aggregation; Postoperative Complications; Pulmonary Embolism; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1980 |
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Heart Diseases; Humans; Hydroxychloroquine; Neoplasms; Sulfinpyrazone; Thromboembolism; Thrombosis | 1982 |
Systemic lupus erythematosus with simultaneous onset of Kikuchi-Fujimoto's disease complicated with antiphospholipid antibody syndrome: a case report and review of the literature.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Anticoagulants; Antiphospholipid Syndrome; Antirheumatic Agents; Aspirin; Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heparin; Histiocytic Necrotizing Lymphadenitis; Humans; Hydroxychloroquine; Injections, Intravenous; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Treatment Outcome; Venous Thrombosis | 2005 |
Insights into atherosclerosis therapy in antiphospholipid syndrome.
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Atherosclerosis; beta 2-Glycoprotein I; Heparin; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents | 2007 |
ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis?
Topics: Adult; Anticoagulants; Aspirin; Double-Blind Method; Drug Therapy, Combination; Evidence-Based Medicine; Female; Humans; Hydroxychloroquine; Incidental Findings; Lupus Coagulation Inhibitor; Partial Thromboplastin Time; Practice Guidelines as Topic; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Reference Values; Thromboembolism; Thrombophilia; Unnecessary Procedures | 2009 |
Lupus and pregnancy: integrating clues from the bench and bedside.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Azathioprine; Counseling; Enzyme Inhibitors; Female; Fetal Death; Heparin; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Postpartum Period; Practice Guidelines as Topic; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Prenatal Care; Risk Factors | 2011 |
Antiphospholipid antibody syndrome.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; beta 2-Glycoprotein I; Humans; Hydroxychloroquine; Retinal Artery Occlusion; Retinal Vein Occlusion; Warfarin | 2012 |
Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Fetal Growth Retardation; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Treatment Outcome | 2014 |
The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Cohort Studies; Female; Heparin; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Obstetrics; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Thrombosis | 2016 |
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review.
Topics: Adult; Antibodies, Antiphospholipid; Aspirin; Cardiovascular Diseases; Female; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lupus Erythematosus, Systemic; Male; Primary Prevention; Risk Factors | 2017 |
Preventing HIV infection without targeting the virus: how reducing HIV target cells at the genital tract is a new approach to HIV prevention.
Topics: Aspirin; Disease Susceptibility; Female; Genitalia, Female; HIV Infections; HIV Seronegativity; HIV-1; Humans; Hydroxychloroquine; Immunity, Innate; Immunity, Mucosal; Kenya; Randomized Controlled Trials as Topic; Risk Factors; Sex Workers | 2017 |
Antiphospholipid syndrome in obstetrics.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Humans; Hydroxychloroquine; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2018 |
Chronic histiocytic intervillositis (CHI): current treatments and perinatal outcomes, a systematic review and a meta-analysis.
Topics: Abortion, Spontaneous; Adalimumab; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Prednisolone; Pregnancy | 2022 |
Does adding hydroxychloroquine to empiric treatment improve the live birth rate in refractory obstetrical antiphospholipid syndrome? A systematic review.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Birth Rate; Female; Humans; Hydroxychloroquine; Pregnancy; Retrospective Studies | 2023 |
12 trial(s) available for aspirin and hydroxychloroquine
Article | Year |
---|---|
Prevention of postoperative thrombosis by aspirin.
Topics: Aspirin; Clinical Trials as Topic; Drug Evaluation; Hip Joint; Humans; Hydroxychloroquine; Joint Prosthesis; Placebos; Postoperative Complications; Thrombophlebitis | 1977 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thromboembolism; Thrombosis | 1978 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Kidney Diseases; Kidneys, Artificial; Male; Silicone Elastomers; Sulfinpyrazone; Thromboembolism; Thrombosis; Vascular Diseases | 1975 |
The prevention of postoperative deep vein thrombosis.
Topics: Adult; Aspirin; Atmospheric Pressure; Clinical Trials as Topic; Dextrans; Electric Stimulation; Ethylestrenol; Foot; Heparin; Humans; Hydroxychloroquine; Leg; Middle Aged; Movement; Muscles; Phenformin; Polysaccharides; Postoperative Complications; Regional Blood Flow; Sulfuric Acids; Thrombophlebitis | 1975 |
The current status of platelet suppressive drugs in the treatment of thrombosis.
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cardiac Catheterization; Cell Survival; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Myocardial Infarction; Postoperative Complications; Renal Dialysis; Sulfinpyrazone; Thrombocytosis; Thromboembolism | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Fibrinolytic Agents; Humans; Hydroxychloroquine; Postoperative Complications; Pulmonary Embolism; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Thrombosis | 1975 |
Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis.
Topics: Alanine Transaminase; Analysis of Variance; Arthritis, Rheumatoid; Aspartate Aminotransferases; Aspirin; Canada; Drug Therapy, Combination; Follow-Up Studies; Humans; Hydroxychloroquine; Liver; Methotrexate; Product Surveillance, Postmarketing; Prospective Studies; Regression Analysis; United States | 1990 |
Treatment of children with juvenile rheumatoid arthritis.
Topics: Arthritis, Juvenile; Aspirin; Child; Clinical Trials as Topic; Humans; Hydroxychloroquine; Penicillamine | 1986 |
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Heart Diseases; Humans; Hydroxychloroquine; Neoplasms; Sulfinpyrazone; Thromboembolism; Thrombosis | 1982 |
Hydroxychloroquine's Efficacy as an Antiplatelet Agent Study in Healthy Volunteers: A Proof of Concept Study.
Topics: Aspirin; Cardiovascular Diseases; Fibrinogen; Healthy Volunteers; Humans; Hydroxychloroquine; Platelet Aggregation; Platelet Aggregation Inhibitors | 2015 |
Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Certolizumab Pegol; Cholesterol; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Lipid Metabolism; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Sulfasalazine; Treatment Outcome; Triglycerides; Tumor Necrosis Factor-alpha | 2014 |
Using safe, affordable and accessible non-steroidal anti-inflammatory drugs to reduce the number of HIV target cells in the blood and at the female genital tract.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Genitalia, Female; HIV Infections; Humans; Hydroxychloroquine; Kenya; Mucous Membrane; NK Cell Lectin-Like Receptor Subfamily B; Pilot Projects; Proteomics; Sex Workers; T-Lymphocytes | 2018 |
64 other study(ies) available for aspirin and hydroxychloroquine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
The prevention of postoperative venous thromboembolism.
Topics: Anticoagulants; Aspirin; Dextrans; Heparin; Humans; Hydroxychloroquine; Leg; Postoperative Complications; Thromboembolism | 1978 |
Antirheumatic agents.
Topics: Adrenal Cortex Hormones; Antimalarials; Aspirin; Azathioprine; Chloroquine; Cyclophosphamide; Gold; Humans; Hydroxychloroquine; Immunosuppressive Agents; Indomethacin; Penicillamine; Phenylbutazone; Phenylpropionates; Rheumatic Diseases; Salicylates; Sulindac; Tolmetin | 1979 |
Is the antithrombotic activity of "antiplatelet" drugs based on protection of endothelium?
Topics: Animals; Aspirin; Citrates; Clofibrate; Dipyridamole; Endothelium; Female; Hydroxychloroquine; Platelet Aggregation; Rats; Sulfinpyrazone | 1979 |
[Antiplatelet drugs (author's transl)].
Topics: Aspirin; Blood Platelets; Clofibrate; Dipyridamole; Female; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Myocardial Infarction; Nicergoline; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1979 |
Rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Aspirin; Aurothioglucose; Cyclophosphamide; Female; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Ibuprofen; Immunosuppressive Agents; Indomethacin; Middle Aged; Phenylbutazone; Physical Therapy Modalities; Prednisolone; Referral and Consultation | 1975 |
Assessment of anti-inflammatory drugs in the rat using subcutaneous implants of polyurethane foam impregnated with dead tubercle bacilli.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Azathioprine; Biological Assay; Cyclophosphamide; Female; Gold Sodium Thiomalate; Hydroxychloroquine; Inflammation; Mycobacterium tuberculosis; Penicillamine; Phenylbutazone; Polyurethanes; Prednisolone; Rats | 1975 |
Bone and joint diseases in the elderly.
Topics: Activities of Daily Living; Adrenal Cortex Hormones; Age Factors; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Counseling; Diagnosis, Differential; Female; Gold; Gout; Humans; Hydroxychloroquine; Immunosuppressive Agents; Indomethacin; Male; Osteoarthritis; Osteoporosis; Penicillamine; Polymyalgia Rheumatica; Rheumatic Diseases | 1976 |
Orthopedic overview of juvenile rheumatoid arthritis.
Topics: Adolescent; Arthritis, Juvenile; Aspirin; Child; Child, Preschool; Diagnosis, Differential; Female; Humans; Hydroxychloroquine; Occupational Therapy; Physical Therapy Modalities; Synovectomy | 1976 |
Drugs for rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Azathioprine; Costs and Cost Analysis; Drugs, Investigational; Humans; Hydroxychloroquine; Methotrexate; Monitoring, Physiologic; Organogold Compounds; Penicillamine; Sulfasalazine | 1991 |
[Rheumatoid neutrophilic dermatosis].
Topics: Adrenal Cortex Hormones; Aged; Arthritis, Rheumatoid; Aspirin; Drug Therapy, Combination; Humans; Hydroxychloroquine; Male; Neutrophils; Skin Diseases | 1990 |
Therapeutic significance of laboratory results in rheumatic disease.
Topics: Anti-Inflammatory Agents; Arthritis, Reactive; Aspirin; Blood Viscosity; C-Reactive Protein; Captopril; Ceruloplasmin; Clofibrate; Gene Frequency; Gold Sodium Thiomalate; Histidine; HLA Antigens; HLA-B27 Antigen; Humans; Hydroxychloroquine; Phenylacetates; Rheumatic Diseases; Spondylitis; Spondylitis, Ankylosing; Sulfhydryl Compounds; Uveitis | 1985 |
[Clinical use of anti-aggregative agents].
Topics: Aspirin; Dipyridamole; Humans; Hydroxychloroquine; Platelet Adhesiveness; Thromboembolism; Thrombophlebitis; Thrombosis | 1973 |
Treatment of rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Arthritis, Rheumatoid; Aspirin; Chloroquine; Cyclophosphamide; Female; Gold; Humans; Hydroxychloroquine; Indomethacin; Male; Middle Aged; Phenylbutazone; Physical Therapy Modalities; Rest | 1974 |
[Use of indomethacin in combination with other antirheumatic drugs in the therapy of chronic inflammatory rheumatism].
Topics: Arthritis, Rheumatoid; Aspirin; Chronic Disease; Dexamethasone; Drug Synergism; Flufenamic Acid; Gold; Humans; Hydroxychloroquine; Indomethacin; Oxyphenbutazone; Phenylbutazone; Prednisone | 1972 |
Effects of anti-inflammatory drugs on the stability of rat liver lysosomes in vitro.
Topics: Acid Phosphatase; Animals; Anti-Inflammatory Agents; Aspirin; Chloroquine; Flufenamic Acid; Fluorine; Glucuronidase; Hydrocortisone; Hydroxychloroquine; In Vitro Techniques; Indomethacin; Liver; Lysosomes; Male; Membranes; ortho-Aminobenzoates; Oxyphenbutazone; Paramethasone; Phenylbutazone; Rats | 1971 |
Dissimilar effects of anti-inflammatory drugs on stability of lysosomes from peritoneal and circulating leukocytes and liver.
Topics: Acid Phosphatase; Animals; Anti-Inflammatory Agents; Aspirin; Chloroquine; Exudates and Transudates; Flufenamic Acid; Glucuronidase; Hydrocortisone; Hydroxychloroquine; In Vitro Techniques; Indomethacin; Leukocytes; Liver; Lysosomes; Male; Membranes; Oxyphenbutazone; Paramethasone; Peritoneal Cavity; Phenylbutazone; Rabbits; Rats | 1971 |
[Evaluation of a practical use of synthetic antimalarials in the treatment of rheumatoid polyarthritis].
Topics: Aged; Antimalarials; Arthritis, Rheumatoid; Aspirin; Chloroquine; Eye Diseases; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Indomethacin; Male; Middle Aged; Oxyphenbutazone; Prednisone | 1971 |
Gold therapy in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Aspirin; Chloroquine; Gold; Humans; Hydroxychloroquine; Indomethacin; Phenylbutazone | 1965 |
Comparative effect of antirheumatic drugs on adjuvant-induced polyarthritis in rats.
Topics: Animals; Arthritis; Aspirin; Chloroquine; Hydroxychloroquine; Indomethacin; Male; Mycobacterium; Phenylbutazone; Prednisolone; Rats | 1966 |
On the effects of antirheumatic drugs on protein sulphydryl reactivity in human serum.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Blood Proteins; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Penicillamine; Phenylacetates; Sulfhydryl Compounds | 1980 |
[Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification].
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Cyclic AMP; Dextrans; Dipyridamole; Humans; Hydroxychloroquine; Indomethacin; Platelet Aggregation; Prostaglandins; Sulfinpyrazone; Thrombosis; Thromboxane A2 | 1980 |
The use of drugs in rheumatic diseases.
Topics: Analgesics; Anti-Inflammatory Agents; Aspirin; Aurothioglucose; Chloroquine; Colchicine; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Penicillamine; Prednisone; Rheumatic Diseases; Salicylates | 1984 |
Juvenile rheumatoid arthritis.
Topics: Adolescent; Anti-Inflammatory Agents; Arthritis, Juvenile; Aspirin; Child; Child, Preschool; Female; Gold; Humans; Hydroxychloroquine; Joint Prosthesis; Male; Penicillamine; Physical Therapy Modalities; Prednisone; Rheumatoid Factor; Salicylates; Social Support | 1984 |
Drugs in the treatment of thrombo-embolic disease--part I.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Carotid Artery Diseases; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Dose-Response Relationship, Drug; Gastrointestinal Hemorrhage; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1983 |
Pharmacologic treatment of juvenile arthritis.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Arthritis, Juvenile; Aspirin; Child; Gold; Humans; Hydroxychloroquine; Naproxen; Penicillamine; Tolmetin | 1983 |
Enteric-coated aspirin in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Aspirin; Blood Sedimentation; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Penicillamine; Salicylates; Tablets, Enteric-Coated | 1981 |
Treatment of juvenile arthritis.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Arthritis, Juvenile; Aspirin; Child; Female; Gold; Humans; Hydroxychloroquine; Joint Prosthesis; Male; Penicillamine; Psychotherapy; Reye Syndrome; Synovitis; Tablets, Enteric-Coated | 1983 |
Reversible dementia and chorea in a young woman with the lupus anticoagulant.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Autoimmune Diseases; Chorea; Dementia; Depression; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Coagulation Inhibitor; Neuropsychological Tests; Prednisone; Thrombophlebitis | 1996 |
[Current approaches to prevention and treatment of antiphospholipid syndrome].
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Contraceptives, Oral; Enzyme Inhibitors; Female; Glucocorticoids; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Male; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications; Risk Factors; Smoking; Time Factors; Warfarin | 2003 |
MANAGEMENT OF RHEUMATOID ARTHRITIS IN THE ELDERLY PATIENT.
Topics: Adrenal Cortex Hormones; Aged; Analgesics; Analgesics, Non-Narcotic; Antipyretics; Arthritis; Arthritis, Rheumatoid; Aspirin; Chloroquine; Gastrointestinal Hemorrhage; Geriatrics; Gold; Humans; Hydroxychloroquine; Prognosis; Rehabilitation; Rest; Social Work; Surgical Procedures, Operative; Toxicology | 1963 |
INFLAMMATORY POLYARTHRITIC DISEASE. II. THE MANAGEMENT OF RHEUMATOID ARTHRITIS.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumatoid; Aspirin; Chloroquine; Cortisone; Exercise Therapy; Humans; Hydroxychloroquine; Iron; Rest; Toxicology | 1963 |
CHEMOTHERAPY OF ARTHRITIS INDUCED IN RATS BY MYCOBACTERIAL ADJUVANT.
Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Arthritis; Arthritis, Rheumatoid; Aspirin; Betamethasone; Chloroquine; Cortisone; Dexamethasone; Humans; Hydroxychloroquine; Male; Mycobacterium; Paramethasone; Phenylbutazone; Prednisolone; Rats; Research; Salicylates; Sodium Salicylate | 1963 |
HAEMATOLOGICAL SIDE-EFFECTS OF SOME ANTI-RHEUMATIC DRUGS.
Topics: Aminopyrine; Antirheumatic Agents; Aspirin; Blood Platelets; Chloroquine; Colchicine; Complement Fixation Tests; Drug Hypersensitivity; Gold; Humans; Hydroxychloroquine; Meprobamate; Phenacetin; Phenylbutazone; Probenecid; Purpura; Purpura, Thrombocytopenic; Quinacrine; Rheumatic Diseases; Splenectomy; Toxicology | 1963 |
USE OF DRUGS IN THE TREATMENT OF RHEUMATOID ARTHRITIS.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumatoid; Aspirin; Chloroquine; Codeine; Humans; Hydroxychloroquine; Methadone; Morphine; Oxyphenbutazone; Phenylbutazone; Toxicology | 1964 |
[TREATMENT OF ANKYLOSING SPONDYLARTHRITIS].
Topics: Adrenal Cortex Hormones; Aspirin; Chloroquine; Drug Therapy; Exercise Therapy; Humans; Hydroxychloroquine; Orthopedics; Phenylbutazone; Radiotherapy; Spondylitis; Spondylitis, Ankylosing; Surgical Procedures, Operative | 1964 |
[OUR PRESENT EXPERIENCE IN DIAGNOSIS AND TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS].
Topics: Adolescent; Adrenocorticotropic Hormone; Aspirin; Chloroquine; Cortisone; Diagnosis; Drug Therapy; Hydroxychloroquine; Lupus Erythematosus, Systemic; Neutrophils | 1964 |
ISOLATION AND CHARACTERIZATION OF MYCOPLASMAS (PPLO) FROM PATIENTS WITH RHEUMATOID ARTHRITIS, SYSTEMIC LUPUS ERYTHEMATOSUS AND REITER'S SYNDROME.
Topics: Adolescent; Arthritis; Arthritis, Juvenile; Arthritis, Reactive; Arthritis, Rheumatoid; Aspirin; Complement Fixation Tests; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Gold; Humans; Hydroxychloroquine; Kidney; Lupus Erythematosus, Systemic; Mycoplasma; Neutralization Tests; Neutrophils; Pathology; Synovial Fluid; Tissue Culture Techniques | 1965 |
Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy.
Topics: Adult; Aspirin; Autoimmune Diseases; Azathioprine; Cyclosporine; Dexamethasone; Female; Hemoglobins; Hepatitis Antibodies; Hepatitis B Vaccines; Humans; Hydroxychloroquine; Immune System; Immunoglobulin G; Immunoglobulins; Immunosuppressive Agents; Infant; Infant, Newborn; Leukocyte Count; Lymphocyte Count; Male; Platelet Count; Prednisone; Pregnancy; Vaccination | 2004 |
Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Aspirin; Autoantibodies; Autoantigens; Autoimmune Diseases; beta 2-Glycoprotein I; Cerebrovascular Disorders; Cognition Disorders; Cohort Studies; Comorbidity; Diabetes Mellitus; Female; Follow-Up Studies; Glycoproteins; Humans; Hydroxychloroquine; Hypercholesterolemia; Hypertension; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Neuropsychological Tests; Prednisone; Prospective Studies; Ribosomes; Risk Factors; Thromboembolism; Thrombophilia | 2005 |
Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
Topics: Aged; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Atorvastatin; Calcium Carbonate; Cardiomyopathy, Restrictive; Citalopram; Connective Tissue Diseases; Diuretics; Female; Furosemide; Glucosamine; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperpigmentation; Lupus Erythematosus, Systemic; Magnesium; Metolazone; Middle Aged; Naproxen; Omeprazole; Potassium Chloride; Prednisone; Pyrroles; Selective Serotonin Reuptake Inhibitors; Spironolactone | 2008 |
Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Antirheumatic Agents; Aspirin; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Male; Multivariate Analysis; Risk Factors; Sex Characteristics; Thrombosis; Young Adult | 2009 |
Case records of the Massachusetts General Hospital. Case 5-2009. A 47-year-old woman with a rash and numbness and pain in the legs.
Topics: Antibodies, Antinuclear; Antirheumatic Agents; Aspirin; Biopsy; Diagnosis, Differential; Dry Eye Syndromes; Exanthema; Female; Humans; Hydroxychloroquine; Hypesthesia; Leg; Livedo Reticularis; Lupus Erythematosus, Systemic; Middle Aged; Pain; Polyarteritis Nodosa; Skin | 2009 |
Familial chilblain lupus--a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1.
Topics: Adolescent; Aspirin; Biopsy, Needle; Chronic Disease; Disease Progression; Drug Therapy, Combination; Exodeoxyribonucleases; Female; Fluorescent Antibody Technique, Direct; Follow-Up Studies; Gene Expression Regulation; Genetic Predisposition to Disease; Humans; Hydroxychloroquine; Immunohistochemistry; Lupus Erythematosus, Cutaneous; Mutation; Phosphoproteins; Rare Diseases; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2009 |
Prominent Degos-like skin lesions in a patient with chronic cutaneous lupus erythematosus.
Topics: Adult; Antirheumatic Agents; Aspirin; Diagnosis, Differential; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Male; Malignant Atrophic Papulosis; Treatment Outcome | 2010 |
[Narcolepsy associated with systemic lupus erythematosus].
Topics: Adult; Aspirin; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Maintenance Chemotherapy; Methylprednisolone; Narcolepsy; Prednisone | 2011 |
Devic syndrome: can antiphospholipid antibodies be a factor?
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Antirheumatic Agents; Aspirin; Atorvastatin; Azathioprine; Complement C4; Cyclophosphamide; Female; Glucocorticoids; Heparin; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Plasmapheresis; Prednisolone; Pulse Therapy, Drug; Pyrroles; Warfarin | 2012 |
Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study.
Topics: Abortion, Habitual; Adult; Aspirin; Autoantibodies; Autoimmune Diseases; Cell Movement; Chorionic Villi; Female; Fetal Death; Heparin, Low-Molecular-Weight; Histiocytes; Humans; Hydroxychloroquine; Infant, Newborn; Live Birth; Obstetric Labor, Premature; Prednisone; Pregnancy; Prospective Studies; Recurrence | 2015 |
Systemic lupus erythematosus with Degos disease: role of dermatoscopy in diagnosis.
Topics: Adolescent; Aspirin; Biopsy, Needle; Dermoscopy; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunohistochemistry; Lupus Erythematosus, Systemic; Malignant Atrophic Papulosis; Prednisolone; Rare Diseases; Risk Assessment; Severity of Illness Index; Sunscreening Agents; Treatment Outcome | 2017 |
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
Topics: Adult; Antirheumatic Agents; Aspirin; Cardiovascular Diseases; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Platelet Aggregation Inhibitors; Primary Prevention; Young Adult | 2017 |
Therapeutic adherence in patients with systemic lupus erythematosus: a cross-sectional study.
Topics: Adolescent; Adult; Age of Onset; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Sectional Studies; Educational Status; Employment; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Income; Lupus Erythematosus, Systemic; Male; Medication Adherence; Middle Aged; Surveys and Questionnaires; Young Adult | 2018 |
Obstetrical morbidity related to anti-SSA antibodies: Data from a French monocentric retrospective study.
Topics: Adult; Antibodies, Antinuclear; Antiphospholipid Syndrome; Aspirin; Databases, Factual; Female; France; Humans; Hydroxychloroquine; Incidence; Middle Aged; Morbidity; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prognosis; Retrospective Studies; Risk Assessment; Sjogren's Syndrome; Treatment Outcome; Young Adult | 2019 |
[Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome].
Topics: Abortion, Habitual; Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Infant, Newborn; Pharmaceutical Preparations; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies | 2018 |
EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies.
Topics: Adult; Algorithms; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Aspirin; beta 2-Glycoprotein I; Case-Control Studies; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Immunoglobulin G; Immunoglobulin M; Longitudinal Studies; Pregnancy; Pregnancy Complications; Retrospective Studies; Risk Assessment | 2021 |
Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Hydroxychloroquine; Logistic Models; Multivariate Analysis; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Risk Factors | 2020 |
Refractory leg ulcers in prolidase deficiency with antiphospholipid antibody positivity responding to aspirin-hydroxychloroquine-vitamin C combination therapy.
Topics: Antibodies, Antiphospholipid; Ascorbic Acid; Aspirin; Humans; Hydroxychloroquine; Leg Ulcer; Prolidase Deficiency | 2020 |
Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Endothelial Cells; Female; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Male; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2022 |
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antirheumatic Agents; Aspirin; Drug Tapering; Europe; Female; Glucocorticoids; Guideline Adherence; Hospitalization; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Mass Screening; Osteoporosis; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pre-Eclampsia; Prednisone; Pregnancy; Quality Indicators, Health Care; Remission Induction; Reproducibility of Results; Risk Assessment; Societies, Medical; Symptom Flare Up | 2021 |
Eculizumab for refractory thrombosis in antiphospholipid syndrome.
Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antiphospholipid Syndrome; Aspirin; Clopidogrel; Female; Fondaparinux; Humans; Hydroxychloroquine; Thrombosis | 2022 |
Sjögren syndrome is a hidden contributor of macrovascular and microvascular complications in patients with type 2 diabetes.
Topics: Aspirin; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Risk Factors; Sjogren's Syndrome | 2022 |
Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Nephritis; Perinatology; Pregnancy; Pregnancy Complications; Referral and Consultation | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies | 2023 |
Benefits of Hydroxychloroquine Combined with Low-Dose Aspirin on Pregnancy Outcomes and Serum Cytokines in Pregnant Women with Systemic Lupus Erythematosus.
Topics: Antirheumatic Agents; Aspirin; Cytokines; Female; Humans; Hydroxychloroquine; Infant, Newborn; Lupus Erythematosus, Systemic; Pregnancy; Pregnancy Outcome; Pregnant Women | 2023 |
Cell-free fetal DNA impairs trophoblast migration in a TLR9-dependent manner and can be reversed by hydroxychloroquine.
Topics: Aspirin; Cell Line; Cell-Free Nucleic Acids; DNA; Female; Humans; Hydroxychloroquine; Placenta; Pre-Eclampsia; Pregnancy; Toll-Like Receptor 9; Trophoblasts | 2023 |